All Market Authorization Holders of medicines are hereby informed that if any new medicine application was submitted to the NMRA on or before 30 September 2024 and the initial evaluation has not yet been received, you are kindly requested to inform the  NMRA accordingly.
‍

Please send the required information to the following email address:
pa15@nmra.gov.lk
‍

When submitting the information, please:

• Use the email subject as:
  “Pending evaluations : Medicine applications submitted before 30 September 2024”
• Provide all relevant details of the application using the attached Excel template.

Please note that the completed Excel template and related information needs to be submitted on or before 4.00 p.m. on Wednesday, 28 January 2026.
‍

Click Here:  Excel template

‍

Thank you.
National Medicines Regulatory Authority
Sri Lanka

‍